Ethic Inc. Abbott Laboratories Transaction History

Ethic Inc.

$3.97 Billion
Q3 2024

A detailed history of Ethic Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Ethic Inc. holds 167,397 shares of ABT stock, worth $19.6 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares

167,397

Previous 171,500 2.39%

Holding current value

$19.6 Million

Previous $17.8 Million 7.09%

% of portfolio

0.48%

Previous 0.42%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$100.07 - $118.13 $410,587 - $484,687	-4,103 Reduced 2.39%	167,397 $19.1 Million
Q2 2024 Aug 13, 2024	BUY	$100.73 - $112.44 $413,295 - $461,341	4,103 Added 2.45%	171,500 $17.8 Million
Q1 2024 May 13, 2024	BUY	$109.52 - $120.96 $1.83 Million - $2.02 Million	16,736 Added 11.11%	167,397 $19 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $1.27 Million - $1.55 Million	14,067 Added 10.3%	150,661 $16.6 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $453,194 - $543,757	4,744 Added 3.6%	136,594 $13.2 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $917,904 - $1.02 Million	9,108 Added 7.42%	131,850 $14.4 Million
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $1.84 Million - $2.17 Million	19,036 Added 18.36%	122,742 $12.4 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $167,115 - $196,052	1,758 Added 1.72%	103,706 $11.4 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $772,822 - $894,783	7,987 Added 8.5%	101,948 $9.87 Million
Q2 2022 Aug 10, 2022	BUY	$102.07 - $123.37 $1.86 Million - $2.24 Million	18,187 Added 24.0%	93,961 $10.2 Million
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $2.42 Million - $2.95 Million	21,187 Added 38.81%	75,774 $8.97 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $341,853 - $418,580	-2,959 Reduced 5.14%	54,587 $7.68 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $4.47 Million - $4.94 Million	38,297 Added 198.96%	57,546 $6.8 Million
Q2 2021 Aug 10, 2021	SELL	$105.79 - $124.53 $783,269 - $922,020	-7,404 Reduced 27.78%	19,249 $2.23 Million
Q1 2021 May 13, 2021	BUY	$108.84 - $128.23 $759,594 - $894,917	6,979 Added 35.47%	26,653 $3.19 Million
Q4 2020 Feb 10, 2021	BUY	$105.0 - $114.42 $484,470 - $527,933	4,614 Added 30.64%	19,674 $2.15 Million
Q3 2020 Oct 27, 2020	BUY	$91.64 - $111.29 $483,950 - $587,722	5,281 Added 54.0%	15,060 $1.64 Million
Q2 2020 Aug 12, 2020	SELL	$76.57 - $98.0 $180,016 - $230,398	-2,351 Reduced 19.38%	9,779 $894,000
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $74,064 - $108,302	-1,179 Reduced 8.86%	12,130 $957,000
Q4 2019 May 22, 2020	BUY	$78.51 - $87.4 $144,536 - $160,903	1,841 Added 16.05%	13,309 $1.16 Million
Q4 2019 Feb 13, 2020	BUY	$78.51 - $87.4 $900,352 - $1 Million	11,468 New	11,468 $996,000

Others Institutions Holding ABT

# of Institutions

3,184

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ethic Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ethic Inc. with notifications on news.

Account